Access to Vaccine

More than 3 million lives saved in the world every year..., but more than 3 million people still die due to a lack of access to existing vaccines.

JMI Vaccine Ltd. wants everyone to have access to its existing vaccines – no matter where they live.

The cost of vaccine administration, weak health systems, and in some cases conflict, mean that many people living in the world’s poorest countries do not have access to vaccines. We have ongoing partnerships with a number of international organizations including the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF) and the Red Cross, through which we supply vaccines where they are needed most. For them, we have developed adapted presentations and implemented tiered-pricing policies.

GAVI Alliance was founded in 2000 by the Bill & Melinda Gates Foundation, the World Bank, WHO, UNICEF and vaccine manufacturers, including JMI Vaccine Ltd.. Committed to saving children’s lives and protecting people’s health through the widespread use of vaccines, GAVI Alliance’s driving objective is to make a critical contribution to global immunization goals by supporting immunization programs and health systems, and accelerating the introduction of new vaccines.

JMI Vaccine Ltd. shares GAVI Alliance’s objectives to improve the infrastructures required for proper vaccine administration and to encourage research and development programs focused on diseases that predominantly affect developing countries, and has historically practiced a policy of tiered pricing to facilitate access to vaccines in GAVI Alliance countries.

GPEI, spearheaded by national governments, WHO, Rotary International, the United States’ Centers for Disease Control and Prevention (CDC) and UNICEF, is the largest public health initiative the world has ever known. Since 1988, some two billion children around the world have been immunized against polio thanks to the unprecedented cooperation of more than 200 countries and 20 million volunteers, backed by an international investment of US$3 billion. As a reliable supplier and partner, JMI Vaccine Ltd. remains fully committed to support the GPEI. Our company is the largest corporate donor to GPEI. Since 1988, we have donated 120 million doses of oral polio vaccine for the immunization of children in five war-ravaged African countries: Angola, Liberia, Sierra Leone, Somalia and Southern Sudan.

EPIVAC program is a JMI Vaccine Ltd. contribution to the GAVI Alliance. Implemented by the Agence de Médecine Préventive, the program was developed in partnership with national governments of eligible countries and the participating universities (Cocody-Abidjan in Ivory Coast, and Paris-Dauphine in France), in collaboration with the WHO, UNICEF, the Vaccine Fund and other partners working in Asia.

The objective of this program is to train doctors involved in the implementation of immunization programs in eleven Central and West African countries.

By providing medical personnel with crucial training in epidemiology, applied computing, vaccinology, and management of health programs, this diploma course in organization and management of immunization in developing countries will help improve access to vaccines in some of the poorest countries in the world